← Latest Filings

S

Shenouda Maged

Chief Financial Officer

Open-market buys

4

$2.0M total

Open-market sells

0

$0 total

Tracking since

Nov 2025

Activity timeline

Open-market buy — $339K

RELMADA THERAPEUTICS, INC. · Sep 10, 2026

Open-market buy — $505K

RELMADA THERAPEUTICS, INC. · Sep 9, 2026

Open-market trades from the last two years.

Holdings as last reported

1,000,000 Common Stock in RLMD

Held directly · as of 2026-09-10

828,000 Stock Appreciation Rights in RLMD

Held directly · as of 2025-12-12

Companies touched

RELMADA THERAPEUTICS, INC.